Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1145]

Understanding the use of PARPi combinations to treat patients with mCRPC

Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof...

Understanding the use of PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard )

Enzalutamide treatment boosted by Radium-223 in mCRPC

Prof Silke Gillessen - Oncology Institute of Southern Switzerland, Bellinzona...

Enzalutamide treatment boosted by Radium-223 in mCRPC ( Prof Silke Gillessen - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof...

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear...

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear cell RCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Nivolumab plus ipilimumab improves efficacy versus standard of care in non...

Prof Lothar Bergmann - University Hospital Frankurt, Frankfurt am Main, Germany

Nivolumab plus ipilimumab improves efficacy versus standard of care in non-clear-cell renal cell carcinomas ( Prof Lothar Bergmann - University Hospital Frankurt, Frankfurt am Main, Germany )

Repeat immune checkpoint inhibitor therapy not recommended for aRCC

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Repeat immune checkpoint inhibitor therapy not recommended for aRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )

Association of adult attachment with delays in accessing specialist care in...

Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer ( Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India )

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )

Depression in cancer

Ms. Bidisha Samanta - Rocket Health, Kolkata, India

Depression in cancer ( Ms. Bidisha Samanta - Rocket Health, Kolkata, India )

Managing 'fear of recurrence' of cancer patients

Ms Bincy Mathew - Manipal Hospitals, Bangalore, India

Managing 'fear of recurrence' of cancer patients ( Ms Bincy Mathew - Manipal Hospitals, Bangalore, India )

More from ecancer